FDA Section 4 \u2022 who must NOT take this
Rivaroxaban - Contraindications
These conditions, allergies, and situations mean Rivaroxaban should NOT be used. From the US FDA-approved drug label Section 4.
4 CONTRAINDICATIONS XARELTO is contraindicated in patients with: active pathological bleeding [see Warnings and Precautions ] severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see Adverse Reactions ] Active pathological bleeding Severe hypersensitivity reaction to XARELTO